BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 17222947)

  • 1. Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease.
    Kauppinen TM
    Neurochem Int; 2007 Jun; 50(7-8):954-8. PubMed ID: 17222947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of poly(ADP-ribose) polymerase-1 in CNS disease.
    Kauppinen TM; Swanson RA
    Neuroscience; 2007 Apr; 145(4):1267-72. PubMed ID: 17084037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
    Virág L; Szabó C
    Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.
    Peralta-Leal A; Rodríguez-Vargas JM; Aguilar-Quesada R; Rodríguez MI; Linares JL; de Almodóvar MR; Oliver FJ
    Free Radic Biol Med; 2009 Jul; 47(1):13-26. PubMed ID: 19362586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting poly(ADP-ribose)polymerase1 in neurological diseases: A promising trove for new pharmacological interventions to enter clinical translation.
    Sriram CS; Jangra A; Kasala ER; Bodduluru LN; Bezbaruah BK
    Neurochem Int; 2014 Oct; 76():70-81. PubMed ID: 25049175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation.
    Erdélyi K; Bakondi E; Gergely P; Szabó C; Virág L
    Cell Mol Life Sci; 2005 Apr; 62(7-8):751-9. PubMed ID: 15868400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K; Besson VC; Szabó C
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Poly(ADP-ribose) polymerase (PARP): physiological and pathological roles].
    Makogon NV; Aleksieieva IM
    Fiziol Zh (1994); 2012; 58(3):95-112. PubMed ID: 22946318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of early biphasic activation of poly(ADP-ribose) polymerase-1 in response to ultraviolet B radiation.
    Vodenicharov MD; Ghodgaonkar MM; Halappanavar SS; Shah RG; Shah GM
    J Cell Sci; 2005 Feb; 118(Pt 3):589-99. PubMed ID: 15657079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress.
    Decker P; Muller S
    Curr Pharm Biotechnol; 2002 Sep; 3(3):275-83. PubMed ID: 12164482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE; Helleday T
    Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.
    Luo X; Kraus WL
    Genes Dev; 2012 Mar; 26(5):417-32. PubMed ID: 22391446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation of cell death by poly(ADP-ribose) polymerase-1.
    Koh DW; Dawson TM; Dawson VL
    Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly (ADP-ribose) polymerase (PARP) is essential for sulfur mustard-induced DNA damage repair, but has no role in DNA ligase activation.
    Bhat KR; Benton BJ; Ray R
    J Appl Toxicol; 2006; 26(5):452-7. PubMed ID: 16906506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD+ as a metabolic link between DNA damage and cell death.
    Ying W; Alano CC; Garnier P; Swanson RA
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase inhibitors.
    Southan GJ; Szabó C
    Curr Med Chem; 2003 Feb; 10(4):321-40. PubMed ID: 12570705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.